Literature DB >> 24909815

Molecular dynamics study of the conformations of glycosidic linkages in sialic acid modified ganglioside GM3 analogues.

G Jaishree1, D Jeya Sundara Sharmila.   

Abstract

The objective of the present study is to model the analogues of monosialoganglioside (GM3) by making modifications in its sialic acid residue with different substitutions in aqueous environment and to determine their structural stability based upon computational molecular dynamics. Molecular mechanics and molecular dynamics investigation was carried out to study the conformational preferences of the analogues of GM3. Dynamic simulations were carried out on the analogues of GM3 varying in the substituents at C-1, C-4, C-5, C-8 and C-9 positions of their sialic acid or Neuraminic acid (NeuAc) residue. The analogues are soaked in a periodic box of TIP3P water as solvent and subjected to a 10 ns molecular dynamics (MD) simulation using AMBER ff03 and gaff force fields with 30 ps equilibration. The analogue of GM3 with 9-N-succNeuAc (analogue5, C9 substitution) was observed to have the lowest energy of -6112.5 kcal/mol. Graphical analysis made on the MD trajectory reveals the direct and water mediated hydrogen bonds existing in these sialic acid analogues. The preferable conformations for glycosidic linkages of GM3 analogues found in different minimum energy regions in the conformational maps were identified. This study sheds light on the conformational preferences of GM3 analogues which may be essential for the design of GM3 analogues as inhibitors for different ganglioside specific pathogenic proteins such as bacterial toxins, influenza toxins and neuraminidases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24909815     DOI: 10.1007/s10719-014-9532-z

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  28 in total

Review 1.  Physiology and pathophysiology of sphingolipid metabolism and signaling.

Authors:  A Huwiler; T Kolter; J Pfeilschifter; K Sandhoff
Journal:  Biochim Biophys Acta       Date:  2000-05-31

2.  Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography.

Authors:  N K Sauter; J E Hanson; G D Glick; J H Brown; R L Crowther; S J Park; J J Skehel; D C Wiley
Journal:  Biochemistry       Date:  1992-10-13       Impact factor: 3.162

3.  Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc.

Authors:  Juan P Oliva; Zodilina Valdés; Angel Casacó; Gilmara Pimentel; Joaquín González; Irene Alvarez; Martha Osorio; Milagros Velazco; Mariela Figueroa; Rosa Ortiz; Xiomara Escobar; Maiby Orozco; Julia Cruz; Sonia Franco; Mirtha Díaz; Lourdes Roque; Adriana Carr; Ana M Vázquez; Cristina Mateos; María C Rubio; Rolando Pérez; Luis E Fernández
Journal:  Breast Cancer Res Treat       Date:  2005-12-02       Impact factor: 4.872

Review 4.  Gangliosides: structure, isolation, and analysis.

Authors:  R W Ledeen; R K Yu
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Conformations of higher gangliosides and their binding with cholera toxin - investigation by molecular modeling, molecular mechanics, and molecular dynamics.

Authors:  D Jeya Sundara Sharmila; K Veluraja
Journal:  J Biomol Struct Dyn       Date:  2006-06

6.  Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients.

Authors:  Marcelo D Guthmann; Mónica A Castro; Gabriela Cinat; Cecilia Venier; Leonardo Koliren; Roberto J Bitton; Ana María Vázquez; Leonardo Fainboim
Journal:  J Immunother       Date:  2006 Mar-Apr       Impact factor: 4.456

7.  Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis -platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside.

Authors:  Subhash Basu; Rui Ma; Patrick J Boyle; Brian Mikulla; Mathew Bradley; Bradley Smith; Manju Basu; Sipra Banerjee
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

8.  Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1.

Authors:  A Hashiramoto; H Mizukami; T Yamashita
Journal:  Oncogene       Date:  2006-02-20       Impact factor: 9.867

9.  Structure and function of a ganglioside receptor for porcine rotavirus.

Authors:  M D Rolsma; T B Kuhlenschmidt; H B Gelberg; M S Kuhlenschmidt
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine.

Authors:  Adriana Carr; Edmundo Rodríguez; María del Carmen Arango; Rolando Camacho; Marta Osorio; Mariano Gabri; Guido Carrillo; Zolidina Valdés; Yanín Bebelagua; Rolando Pérez; Luis Enrique Fernández
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.